Large gap with delayed quotes
|
Last quote
08/15/2026
-
02:00:00
|
Bid
08/14/2026 -
21:59:58
|
Bid Volume |
Ask
08/14/2026 -
21:59:58
|
Ask Volume |
|---|---|---|---|---|
|
62.35
-1.88
(
-2.93% )
|
62.34
|
2,600 |
62.41
|
400 |
Analysis date: 14.08.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 23.06.2026.
Interest
Weak
Weak
Two stars since 07.08.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 10.07.2026 at a price of 68.92.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 26.06.2026.
4wk Rel Perf
-10.57%
-10.57%
The four-week dividend-adjusted underperformance versus SP500 is 10.57%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 12.05.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.36%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.89%.
Mkt Cap in $bn
6.04
6.04
With a market capitalization between $2 & $8bn, XENON PHARMACEUTICALS is considered a mid-cap stock.
G/PE Ratio
0.12
0.12
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
364.17
364.17
The estimated PE is for the year 2029.
LT Growth
44.28%
44.28%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
79
79
For 1% of index variation, the stock varies on average by 0.79%.
Correlation
0.17
0.17
Stock movements are totally independent of index variations.
Value at Risk
14.96
14.96
The value at risk is estimated at USD 14.96. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025